The board of directors of Sinopharm Tech Holdings Limited (the "Company") announces that the Company's head office and principal place of business in Hong Kong will be changed to Unit 1802, 18/F, Ruttonjee House, Ruttonjee Centre, 11 Duddell Street, Central, Hong Kong with effect from 25 September 2023.
Sinopharm Tech Holdings Limited
Equities
8156
KYG2159V1418
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.116 HKD | +18.37% | +0.87% | -12.12% |
Feb. 29 | Sinopharm Tech Holdings Limited Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 | CI |
2023 | Sinopharm Tech Holdings Limited Announces Management Changes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.12% | 2.31M | |
-6.23% | 180B | |
+2.59% | 112B | |
-2.75% | 68.53B | |
+5.32% | 51.97B | |
+7.61% | 44.08B | |
+5.62% | 42.23B | |
+25.17% | 32.43B | |
+16.72% | 26.39B | |
-2.66% | 24.97B |
- Stock Market
- Equities
- 8156 Stock
- News Sinopharm Tech Holdings Limited
- Sinopharm Tech Holdings Limited Announces Change of Head Office and Principal Place of Business in Hong Kong